Dr Reddy’s settles case with Nordion

PTI New Delhi | Updated on March 13, 2018 Published on March 23, 2013

dr reddy

Dr Reddy's Laboratories has informed the BSE that it has settled claims with the Ottawa, Canada-based Nordion Inc (formerly MDS Inc.).

In the case pending in the New Jersey District Court of the US, Nordion settled the case against it by paying $22.5 million (Rs 122.27 crore) to DRL. The settlement was concluded on March 20.

The case was brought by DRL in April 2009 seeking damages caused by a claimed breach by the former MDS of its laboratory services agreement with it (DRL).

The Canadian company, as a contract research firm, provided lab services to Dr Reddy’s, including bio-equivalency studies to support its regulatory applications for approval of generic drugs.

PTI adds: “The case arose after the USFDA cited MDS with violations of good laboratory practices which caused the USFDA not to accept, without further substantiation, MDS’s laboratory reports performed during the period 2000-2004,” Dr Reddy's said in a statement.

Published on March 23, 2013
This article is closed for comments.
Please Email the Editor